Community People and Culture Yaniris Silva Reflects on the Power of Life-Changing Opportunities September 29, 2026
People and Culture Cristin Hubbard Reflects on a Career Spent Bringing Innovation to Patients – and Why Working at BioMarin Has Her More Energized Than Ever August 7, 2026
Community People and Culture Yaniris Silva Reflects on the Power of Life-Changing Opportunities September 29, 2026
People and Culture Science Bringing Science Full Circle: Ben Schooler Shares What Has Motivated His Path at BioMarin August 25, 2026
People and Culture Cristin Hubbard Reflects on a Career Spent Bringing Innovation to Patients – and Why Working at BioMarin Has Her More Energized Than Ever August 7, 2026
BioMarin Presents New Data Advancing Understanding of Achondroplasia and Hypochondroplasia Treatment at the American Society for Bone and Mineral Research Annual Meeting October 9, 2026
BioMarin Announces Five-Year Phase 3 Data for POMBILITI® (cipaglucosidase alfa-atga) + OPFOLDA® (miglustat) at World Muscle Society Annual Congress October 2, 2026
BioMarin Announces Appointment of Robert Plenge, M.D., Ph.D., Chief Research Officer of Bristol Myers Squibb, to Board of Directors September 14, 2026
BioMarin Announces Positive Results of Phase 3 VOXZOGO® (vosoritide) Study in Hypochondroplasia Published in NEJM Evidence September 9, 2026